Cargando…

Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options

Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan, China has infected more than 6.7 million individuals and killed more than 390,000 individuals globally. Due to the higher transmissibility and infectiousness, asymptomatic infection, and lack of effective treatment options and vaccine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Suliman, Siddique, Rabeea, Bai, Qian, Shabana, Liu, Yang, Xue, Mengzhou, Nabi, Ghulam, Liu, Jianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381894/
https://www.ncbi.nlm.nih.gov/pubmed/32741731
http://dx.doi.org/10.1016/j.jiph.2020.07.010
_version_ 1783563142832324608
author Khan, Suliman
Siddique, Rabeea
Bai, Qian
Shabana
Liu, Yang
Xue, Mengzhou
Nabi, Ghulam
Liu, Jianbo
author_facet Khan, Suliman
Siddique, Rabeea
Bai, Qian
Shabana
Liu, Yang
Xue, Mengzhou
Nabi, Ghulam
Liu, Jianbo
author_sort Khan, Suliman
collection PubMed
description Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan, China has infected more than 6.7 million individuals and killed more than 390,000 individuals globally. Due to the higher transmissibility and infectiousness, asymptomatic infection, and lack of effective treatment options and vaccine, fatalities and morbidities are increasing day by day globally. Despite physical health consequences, COVID-19 pandemic has created stress and anxiety, as result there is an increased risk of mental illnesses both in the infected and normal individuals. To eradicate these risks, it is necessary to determine the COVID-19 zoonotic source of transmission to humans and clinical manifestations in infected individuals. Although, identification or development of the highly effective therapeutic agents is necessary, however, development of protective strategies against the COVID-19 by enhancing immune responses will be an asset in the current scenarios of the COVID-19 pandemic. In this paper, we discuss the transmission, health consequences, and potential management (therapeutic and preventive) options for COVID-19 disease.
format Online
Article
Text
id pubmed-7381894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
record_format MEDLINE/PubMed
spelling pubmed-73818942020-07-28 Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options Khan, Suliman Siddique, Rabeea Bai, Qian Shabana Liu, Yang Xue, Mengzhou Nabi, Ghulam Liu, Jianbo J Infect Public Health Review Article Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan, China has infected more than 6.7 million individuals and killed more than 390,000 individuals globally. Due to the higher transmissibility and infectiousness, asymptomatic infection, and lack of effective treatment options and vaccine, fatalities and morbidities are increasing day by day globally. Despite physical health consequences, COVID-19 pandemic has created stress and anxiety, as result there is an increased risk of mental illnesses both in the infected and normal individuals. To eradicate these risks, it is necessary to determine the COVID-19 zoonotic source of transmission to humans and clinical manifestations in infected individuals. Although, identification or development of the highly effective therapeutic agents is necessary, however, development of protective strategies against the COVID-19 by enhancing immune responses will be an asset in the current scenarios of the COVID-19 pandemic. In this paper, we discuss the transmission, health consequences, and potential management (therapeutic and preventive) options for COVID-19 disease. The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020-12 2020-07-25 /pmc/articles/PMC7381894/ /pubmed/32741731 http://dx.doi.org/10.1016/j.jiph.2020.07.010 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Khan, Suliman
Siddique, Rabeea
Bai, Qian
Shabana
Liu, Yang
Xue, Mengzhou
Nabi, Ghulam
Liu, Jianbo
Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options
title Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options
title_full Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options
title_fullStr Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options
title_full_unstemmed Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options
title_short Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options
title_sort coronaviruses disease 2019 (covid-19): causative agent, mental health concerns, and potential management options
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381894/
https://www.ncbi.nlm.nih.gov/pubmed/32741731
http://dx.doi.org/10.1016/j.jiph.2020.07.010
work_keys_str_mv AT khansuliman coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions
AT siddiquerabeea coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions
AT baiqian coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions
AT shabana coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions
AT liuyang coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions
AT xuemengzhou coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions
AT nabighulam coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions
AT liujianbo coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions